CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 79 filers reported holding CYTOSORBENTS CORP in Q2 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,366,317 | -49.9% | 726,764 | -4.4% | 0.00% | – |
| Q2 2023 | $2,728,439 | +8.7% | 760,011 | +2.0% | 0.00% | – |
| Q1 2023 | $2,510,326 | +118.3% | 744,904 | +0.4% | 0.00% | – |
| Q4 2022 | $1,150,188 | +14.0% | 742,057 | +0.1% | 0.00% | – |
| Q3 2022 | $1,009,000 | -38.2% | 741,371 | -0.5% | 0.00% | – |
| Q2 2022 | $1,632,000 | -80.3% | 744,958 | -71.4% | 0.00% | – |
| Q1 2022 | $8,295,000 | -24.8% | 2,600,437 | -1.2% | 0.00% | – |
| Q4 2021 | $11,024,000 | -46.9% | 2,631,210 | +2.8% | 0.00% | -100.0% |
| Q3 2021 | $20,777,000 | +4.2% | 2,558,792 | -3.1% | 0.00% | 0.0% |
| Q2 2021 | $19,941,000 | -18.8% | 2,641,166 | -6.6% | 0.00% | 0.0% |
| Q1 2021 | $24,552,000 | +11.5% | 2,828,602 | +2.4% | 0.00% | 0.0% |
| Q4 2020 | $22,016,000 | +2.5% | 2,762,288 | +2.6% | 0.00% | 0.0% |
| Q3 2020 | $21,481,000 | -5.1% | 2,693,532 | +17.8% | 0.00% | 0.0% |
| Q2 2020 | $22,630,000 | +39.6% | 2,285,783 | +9.0% | 0.00% | 0.0% |
| Q1 2020 | $16,207,000 | +104.4% | 2,096,648 | +1.8% | 0.00% | – |
| Q4 2019 | $7,930,000 | -23.5% | 2,059,602 | -0.0% | 0.00% | – |
| Q3 2019 | $10,363,000 | -21.9% | 2,060,179 | +2.6% | 0.00% | -100.0% |
| Q2 2019 | $13,274,000 | -11.7% | 2,008,123 | +1.1% | 0.00% | 0.0% |
| Q1 2019 | $15,037,000 | -6.3% | 1,986,332 | +0.0% | 0.00% | 0.0% |
| Q4 2018 | $16,046,000 | -36.6% | 1,985,640 | +1.2% | 0.00% | 0.0% |
| Q3 2018 | $25,308,000 | +30.1% | 1,961,749 | +14.9% | 0.00% | 0.0% |
| Q2 2018 | $19,459,000 | +1931.2% | 1,706,847 | +1156.8% | 0.00% | – |
| Q1 2018 | $958,000 | +5.2% | 135,806 | -3.1% | 0.00% | – |
| Q4 2017 | $911,000 | +7.4% | 140,137 | +2.4% | 0.00% | – |
| Q3 2017 | $848,000 | +75.6% | 136,817 | +22.0% | 0.00% | – |
| Q2 2017 | $483,000 | -9.9% | 112,174 | -5.9% | 0.00% | – |
| Q1 2017 | $536,000 | +26700.0% | 119,173 | +29693.2% | 0.00% | – |
| Q4 2016 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |